Benzinga | Sep 11, 2020 08:04AM EDT

BioDelivery Sciences Reports 5 Scientific Poster Presentations at PAINWeek 2020 National Conference on Pain Management

BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced the presentation of five scientific posters highlighting data regarding BELBUCA at the 14th Annual PAINWeek 2020 National Conference on Pain Management taking place virtually September 11-13, 2020.

Poster Presentations:

2 A Phase I Placebo-Controlled Trial Comparing the Effect of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride: Pupillometry Authors: Lynn Webster, MD; Jacqueline Cater, PhD; Thomas Smith, MD

2 Secondary Outcomes of a Phase I Placebo-Controlled Trial Comparing the Effect of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride on Respiratory Drive Authors: Lynn Webster, MD; Jacqueline Cater, PhD; Thomas Smith, MD

2 Key Outcomes of a Phase I Placebo-Controlled Trial Comparing the Effect of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride on Respiratory Drive Authors: Lynn Webster, MD; Jacqueline Cater, PhD; Thomas Smith, MD

2 The Pharmacodynamics and Pharmacokinetics of Buprenorphine Buccal Film Versus Oral Oxycodone Hydrochloride: Results of a Phase I Placebo-Controlled Trial Authors: Lynn Webster, MD; Jacqueline Cater, PhD; Thomas Smith, MD

2 Buprenorphine Buccal Film in Patients with Chronic Low Back Pain: A Pooled Subgroup Analysis of Two Double-Blind, Placebo-Controlled, Randomized Withdrawal Trials by Baseline Pain Severity Authors: Christine Moore, PhD; P. Hunter Allman, PhD; Gary Cutter, PhD

"We are very pleased to have this data being presented this year at PAINWeek 2020, the largest pain conference in the US," said Thomas Smith, MD, Chief Medical Officer of BDSI. "This new information adds to the growing awareness and appreciation of BELBUCA as an important treatment option for patients suffering from chronic pain."

All five posters will be available for public viewing by visiting the PAINWeek Conference website following the conclusion of the Conference.